COMMUNIQUÉS West-GlobeNewswire

Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company
21/07/2025
CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has [...]
Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference
21/07/2025
WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will [...]
PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025
21/07/2025
MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on Thursday, August 7, [...]
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
21/07/2025
DUBLIN, July 21, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of [...]
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
21/07/2025
BETHLEHEM, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2025 financial results and certain business [...]
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
21/07/2025
SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]
TELA Bio to Announce Second Quarter 2025 Financial Results
21/07/2025
MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
HNL Lab Medicine Opens New Location at Tower Place in Bethlehem
21/07/2025
ALLENTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine is pleased to announce the opening of its newest patient service center at Tower Place – LVHN Health Center, located at 1490 8th Avenue, Bethlehem, PA [...]
UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar
21/07/2025
A first-of-its-kind solution for women’s arousal - the same active ingredient as in Viagra ® for men - in a proprietary topical formulation demonstrated to work where women need it most Targeted to be available by [...]
Second Circuit Affirms Dismissal of Complaint Against Vystar In the Case Of EMA Financial LLC v. Vystar Corp.
21/07/2025
Boston, MA, July 21, 2025 (GLOBE NEWSWIRE) -- Vystar ® Corporation (OTCQB: VYST) On November 27, 2024, the New York federal district court in the case EMA Financial LLC v. Vystar Corp ., 19-cv-1545 (GWG) issued a first [...]
Natural Appetite Suppressant: Why More Are Choosing PhenQ Over Weight Loss Injections for Safer Weight Management Results in 2025
21/07/2025
New York City, NY, July 21, 2025 (GLOBE NEWSWIRE) -- PhenQ is leading the 2025 weight loss revolution with a science-backed natural appetite suppressant —no needles, no harsh side effects, just sustainable, healthy [...]
CARBIOS enters the r-PET market for tire textile filaments
21/07/2025
CARBIOS has signed a multi-year commercial agreement with Indorama Ventures, the world leader in polyester production. CARBIOS will supply recycled monomers that will be transformed into filaments by Indorama Ventures, [...]
CARBIOS entre dans le marché du r-PET destiné aux filaments textiles pour pneumatiques
21/07/2025
CARBIOS a signé un engagement commercial pluriannuel avec Indorama Ventures, leader mondial du polyester. CARBIOS fournira les monomères recyclés qui seront transformés en filaments par Indorama Ventures, et destinés au [...]
REPEAT – Health care advocates afraid of major cuts and privatization hold shadow summit and rally at Council of the Federation next week
21/07/2025
HUNTSVILLE, Ontario, July 21, 2025 (GLOBE NEWSWIRE) -- Outside the Council of the Federation and the gathering of First Ministers, public health care advocates from across Canada will be joining a shadow summit, rally, [...]
Foundation for Sarcoidosis Research Sarc Fighter Podcast Surpasses 100,000 Downloads, Amplifying Voices in the Sarcoidosis Community
21/07/2025
CHICAGO, July 21, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to celebrate a major milestone for the FSR Sarc Fighter Podcast , which has officially surpassed 100,000 downloads since [...]
Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies
21/07/2025
SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Further to our announcement filed on Form 6-K on November 20, 2024 , CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage [...]
Acentra Health Names Marnie Keogh as Senior Vice President of Marketing
21/07/2025
Proven healthcare marketing leader to drive brand growth and digital engagement in support of the company’s mission to innovate health solutions that accelerate better health outcomes MCLEAN, Va., July 21, 2025 (GLOBE [...]
Veteran Global Health Leader, Dr. Rebecca Martin, Named President of Global Immunization at Sabin
21/07/2025
WASHINGTON, July 21, 2025 (GLOBE NEWSWIRE) -- Renowned global health expert Rebecca Martin, PhD, recognized internationally for her leadership in developing and implementing immunization programs and strengthening [...]
Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease
21/07/2025
Longeveron has licensed issued US Patent 12,168,028 B2 , entitled “Methods for obtaining cardiomyogenic precursor cells” from the University of Miami New patent protects a method to derive GHRH-Receptor+ cardiomyogenic [...]

Pages